Safety and pharmacokinetics (PK) of single and multiple ascending oral doses of ALG-055009, a thyroid hormone receptor beta agonist for the treatment of non-alcoholic steatohepatitis (NASH), in healthy volunteers and subjects with hyperlipidemia

Authors
Category Primary study
JournalJournal of Hepatology
Year 2022
This article has no abstract
Epistemonikos ID: cac10e2b9ceb42eed0501a9da7a11470f9059b16
First added on: Feb 14, 2025